Publication Name	World Journal of Gastroenterology
Manuscript ID	8061
Country	Qatar

Received	2013-12-15 08:05
Peer-Review Started	2013-12-15 09:53
To Make the First Decision	2014-01-15 13:22
Return for Revision	2014-01-20 18:47
Revised	2014-02-20 16:02
Second Decision	2014-05-29 20:15
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2014-05-29 20:40
Articles in Press	2014-05-29 21:06
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-09-13 15:40
Publish the Manuscript Online	2014-10-01 20:25

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Infectious Diseases
Manuscript Type	Topic Highlights
Article Title	Potential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: An analysis using hepatitis C virus as a proxy biomarker
Manuscript Source	Invited Manuscript
All Author List	Yousra A Mohamoud, F DeWolfe Miller and Laith J Abu-Raddad
Funding Agency and Grant Number	Funding Agency Grant Number Qatar National Research Fund NPRP 04-924-3-251 Biostatistics, Epidemiology, and Biomathematics Research Core at the Weill Cornell Medical College in Qatar
Corresponding Author	Laith J Abu-Raddad, PhD, Associate Professor, Infectious Disease Epidemiology Group, Weill Cornell Medical College - Qatar, Qatar Foundation - Education City, Doha 24144, Qatar. lja2002@qatar-med.cornell.edu
Key Words	Hepatitis C virus; human immunodeficiency virus; parenteral transmission; Middle East and North Africa; proxy biomarker
Core Tip	The Middle East and North Africa (MENA) region has witnessed several major events of parenterally transmitted infections. Recent studies of hepatitis C virus (HCV) epidemiology established the utility of using HCV as a proxy biomarker for assessing the potential for human immunodeficiency virus (HIV) parenteral transmission. Building on these novel ideas, we used HCV antibody prevalence data to assess the potential for substantial and/or sustainable HIV parenteral transmission in MENA. We found that HCV prevalence levels are consistent with limited potential for parenteral HIV transmission, but that there could be still opportunities for localized and isolated HIV outbreaks, particularly in formal and informal healthcare settings.
Publish Date	2014-10-01 20:25
Citation	Mohamoud YA, Miller FD, Abu-Raddad LJ. Potential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: An analysis using hepatitis C virus as a proxy biomarker. World J Gastroenterol 2014; 20(36): 12734-12752
URL	http://www.wjgnet.com/1007-9327/full/v20/i36/12734.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i36.12734

Full Article (PDF)	WJG-20-12734.pdf
Full Article (Word)	WJG-20-12734.doc
Manuscript File	8061-Review.docx
Answering Reviewers	8061-Answering reviewers.pdf
Copyright License Agreement	8061-Copyright assignment.pdf
Peer-review Report	8061-Peer reivew(s).pdf
Scientific Misconduct Check	8061-CrossCheck.jpg
Scientific Editor Work List	8061-Scientific editor work list.pdf